A Real-World Anti-Diabetes Medication Cost Comparison Between Premixed Insulin Analogs and Long-Acting Insulin Analogs in Chinese Patients with Type 2 Diabetes: A Retrospective Database Analysis
Crossref DOI link: https://doi.org/10.1007/s13300-018-0382-8
Published Online: 2018-02-23
Published Print: 2018-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Gao, Yue
Wang, Ke
Chen, Yun
Shen, Li
Hou, Jianing
Xuan, Jianwei
Liu, Bao
Funding for this research was provided by:
Lilly Suzhou Pharmaceutical Co. Ltd, China
Text and Data Mining valid from 2018-02-23
Article History
Received: 27 December 2017
First Online: 23 February 2018